
By automating front‑desk and exam‑room tasks, Secai can dramatically reduce administrative overhead, boost clinic capacity, and address the growing burnout crisis in healthcare delivery.
Healthcare providers are under mounting pressure from staffing shortages and rising administrative costs, prompting a rapid shift toward AI‑driven efficiency tools. Secai’s two‑pronged approach—Voxira handling patient calls and NoteGen transcribing encounters in real time—directly targets the two most time‑consuming steps in clinical workflows. By removing the bottleneck at the front desk and freeing physicians from manual charting, clinics can see higher patient throughput and lower per‑visit overhead, a compelling value proposition in a market hungry for productivity gains.
Regulatory approval has long been a barrier for AI in clinical settings, where safety and data privacy are paramount. Secai’s TGV certification from Quebec’s Ministry of Health marks the first instance of a voice AI meeting stringent provincial standards, offering a rare stamp of credibility that can accelerate adoption across jurisdictions. This endorsement not only reassures providers about compliance but also positions Secai ahead of competitors still navigating uncertain regulatory pathways. Seamless integration with major EMR platforms further cements its role as an interoperable component of modern health IT stacks.
The $6.2 million infusion signals strong investor confidence in AI‑enabled clinic infrastructure. As Secai scales into the U.S., it taps a multi‑billion‑dollar market where hospitals and outpatient centers are actively seeking solutions to curb burnout and improve patient experience. Continued R&D into "agentic workflows" could push the technology from assistance to autonomous decision support, reshaping how clinics operate. If Secai delivers on its growth roadmap, the company could set a new benchmark for AI’s role as the operating system of the modern clinic, driving both clinical outcomes and financial performance.
By Fred Pennic · 02/13/2026

The Raise: Montreal‑based Secai has closed a $6.2 M Series A financing round to expand its footprint across Canada and the United States.
The Tech: The company offers a two‑pronged solution: Voxira (autonomous voice reception) and NoteGen (clinical documentation). Together, they aim to automate both patient access and the medical encounter itself.
The Credibility: Secai has become the first and only voice AI to receive TGV certification from the Quebec Ministry of Health (August 2025), a massive validation of its safety and compliance in a highly regulated market.
Secai is tackling the two biggest time‑sinks in healthcare simultaneously:
Voxira (The Front Desk): An autonomous voice receptionist that handles patient communications and appointment workflows. It ensures that no patient call goes unanswered, solving the access challenge created by staffing shortages.
NoteGen (The Exam Room): A real‑time documentation tool that integrates directly with Electronic Medical Records (EMR). It captures the patient encounter and structures the data, freeing the physician to focus on care.
“Clinics are no longer asking whether they should use AI, but how quickly they can deploy it,” said Dr. Ragui Ibrahim, President and CEO of Secai. “Our technology helps clinics reclaim hours of administrative time, increase capacity, and reduce burnout. This funding allows us to scale that impact more broadly.”
In August 2025, the company became the first and only voice AI to receive TGV certification from the Quebec Ministry of Health.
The Series A funding will be used to take this proven model nationwide across Canada and into the United States. The capital will also support deeper integrations with major EMR platforms—the lifeblood of any clinical workflow—and advance R&D in “agentic workflows.”
“With this investment, we’re building the operating system of the modern clinic,” added Dr. Ibrahim.
Comments
Want to join the conversation?
Loading comments...